Sign up to save your podcasts
Or
Share ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
View all episodes
By American College of Cardiology
3.8
5858 ratings
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
Investing Insights
525 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
501 Listeners
JACC This Week
162 Listeners
This Week in Cardiology
890 Listeners
JACC Specialty Journals
19 Listeners
Circulation on the Run
31 Listeners
Mayo Clinic Talks
294 Listeners
The Curbsiders Internal Medicine Podcast
3,354 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
ACC CardiaCast
39 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
372 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
Mayo Clinic Cardiovascular CME
34 Listeners